Brigham and Women's Hospital
Boston, Massachusetts, United States
Alex Ling did his PhD in Cancer Biology with Dr. Stephanie Huang at the University of Chicago. There, he developed and utilized computational models for predicting patient drug response, including a method for predicting the clincial efficacy of drug combinations using data from high-throughput cancer cell line drug screens and phase I clinical trials. Following his PhD, Alex began a post-doc with Dr. Antonio Chiocca at Brigham and Women's Hospital. There, he has done both comptuational and bench work aimed at characterization and optimization of an HSV1-based GBM therapy that is currently undergoing clinical testing.
